Skip to main content

Table 2 Outcome and follow-up

From: Clinical characteristics, risk factors and outcome of severe Norovirus infection in kidney transplant patients: a case-control study

Variable Norovirus cases
(n = 72)
n (%); median [IQR]
Controls
(n = 72)
n (%); median [IQR]
p-value
Median duration of follow-up (months) 23.8 [9.2–40.6] 32 [16.6–50] 0.02
Kidney function at last follow-up
 Serum creatinine (μM) 182 [121–231] 146 [114–202] 0.08
 eGFR (ml/min/1.73m2) 38 [24–53] 44 [30–61] 0.16
Immunological outcome
 Number of patients with significant de novo DSA (MFI > 3000) 8 (11) 0 0.01
 Acute rejection 10. (13.8) 3 (4.2) 0.03
 Antibody-mediated rejection 7 (9.7) 2 (2.8)  
 Mixed rejection 3 (4.2) 1 (1.4)  
Return to dialysis 8 (10.7) 5 (6.9) 0.07
Death 3 (4.2) 1 (1.4) 0.61
  1. Abbreviations: eGFR estimated Glomerular Filtration Rate (MDRD), MFI Mean Fluorescence Intensity